Cutaneous corticosteroid injection and amaurosis. Analysis for cause and prevention.
D000506:Alopecia Areata / Q000188:drug therapy; D001766:Blindness / Q000139:chemically induced* / Q000517:prevention & control; D001794:Blood Pressure; D004617:Embolism / Q000139:chemically induced / Q000517:prevention & control; D005123:Eye / Q000098:blood supply; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007271:Injections, Intradermal / Q000009:adverse effects* / Q000379:methods; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D009880:Ophthalmic Artery; D010316:Particle Size; D012535:Scalp; D013535:Suspensions; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use
D013535:Suspensions; D014222:Triamcinolone Acetonide; D006854:Hydrocortisone; D008775:Methylprednisolone